(Q41711842)

7 October 2017

title

Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells (English)

1 reference

7 October 2017

1 reference

Yuengsrigul A

1

1 reference

7 October 2017

Chin TW

series ordinal

2

1 reference

7 October 2017

Nussbaum E

series ordinal

3

1 reference

7 October 2017

publication date

1 December 1999

1 reference

Annals of Allergy, Asthma & Immunology

7 October 2017

published in

1 reference

7 October 2017

volume

83

1 reference

7 October 2017

issue

6 Pt 1

1 reference

7 October 2017

page(s)

559-566

1 reference

Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of inhaled frusemide on the early response to antigen and subsequent change in airway reactivity in atopic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Prevention of exercise-induced bronchoconstriction by inhaled frusemide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Protective effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized H2O. A dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic "fog" of distilled water in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Inhaled furosemide prevents ultrasonically nebulized water bronchoconstriction in children with both atopic and nonatopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

The effect of inhaled frusemide on airway sensitivity to inhaled 4.5% sodium chloride aerosol in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of inhaled furosemide on the bronchial response to methacholine and cold-air hyperventilation challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Inhaled frusemide against cold air induced bronchoconstriction in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of inhaled furosemide on the bronchial response to lysine-aspirin inhalation in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Reversal of bronchial obstruction in children with mild stable asthma by aerosolized furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

The protective effect of frusemide on the generation of superoxide anions by human bronchial epithelial cells and pulmonary macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

1 reference

7 January 2021

Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Cytokines in symptomatic asthma airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

TNFalpha mRNA expression in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Expression of the Potent Inflammatory Cytokines, GM-CSF, IL6, and IL8, in Bronchial Epithelial Cells of Asthmatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Human alveolar macrophage and blood monocyte interleukin-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Intratracheal furosemide in infants after cardiac surgery: its effects on lung mechanics and urinary output, and its levels in plasma and tracheal aspirate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Bronchial response to methacholine in "healthy" children of asthmatic parents. Effect of treatment with cromolyn sodium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Effect of nedocromil sodium on histamine airway responsiveness in grass-pollen sensitive asthmatics during the pollen season

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Attenuation of the metabisulfite-induced bronchoconstrictive response by pretreatment with cromolyn

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

The long-term effect of nedocromil sodium on the maximal degree of airway narrowing to methacholine in atopic asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Disodium cromoglycate inhibits activation of human inflammatory cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Evidence for the anti-inflammatory activity of nedocromil sodium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Anti-inflammatory effects of nedocromil sodium: inhibition of alveolar macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Nedocromil sodium inhibits T-cell function in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

Exercise-induced asthma and the generation of neutrophil chemotactic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962870-0

7 January 2021

10.1016/S1081-1206(10)62870-0

Identifiers

DOI

1 reference

7 October 2017

1 reference